Results 21 to 30 of about 2,408 (165)
Asian Pacific Journal of Cancer Care, 2021 Giant renal cell carcinoma is a rare case. We reported six cases of giant renal cell carcinoma, which required surgical resection of the tumor, including a 9.900 cm3 of encapsulated neoplasm removal. To our knowledge, this is the largest giant clear cell
Sawkar Vijay Pramod +3 more
doaj +1 more source
IJU Case Reports, 2022 Introduction Cytoreductive nephrectomy has been used in combination with systemic therapy for the treatment of metastatic renal cell carcinoma, although its efficacy in the era of immune checkpoint inhibitors remains controversial. Case presentation A 57‐
Takanari Kambe +9 more
doaj +1 more source
Role of cytoreductive nephrectomy in the targeted therapy era: A systematic review and meta-analysis [PDF]
Investigative and Clinical Urology, 2018 Purpose: To determine the effectiveness and harm of cytoreductive nephrectomy versus no intervention in patients with metastatic renal carcinoma who undergo targeted therapy to improve overall survival.
Herney A. García-Perdomo +2 more
doaj +1 more source
Cytoreductive nephrectomy in the age of immunotherapy-based combination treatment. [PDF]
Investig Clin Urol, 2023 Renal cell carcinoma (RCC) displays a wide spectrum of oncological prognosis and clinical behavior, and is noted for its generally poor outcome in metastatic settings. However, the introduction of immunotherapy after the cytokine era has changed the landscape of treatment for metastatic RCC, outperforming previous targeted therapy and providing new ...
Song SH, Lee S.
europepmc +4 more sources
Chinese Medical Journal, 2016 Background: The metastatic renal cell carcinoma (mRCC) patients treated with upfront cytoreductive nephrectomy combined with α-interferon yields additional overall survival (OS) benefits.
Yan Song +12 more
doaj +1 more source
IJU Case Reports, 2023 Introduction Combination therapy using immuno‐oncology drugs with tyrosine kinase inhibitors is increasingly important in the therapeutic strategy for metastatic renal cell carcinomas.
Hiroaki Sato +9 more
doaj +1 more source
Cytoreductive nephrectomy and its role in the present-day period of targeted therapy
Therapeutic Advances in Urology, 2015 The beneficial effect of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma in the immunotherapy era was based on two prospective randomized trials.
Stephen H. Culp
doaj +1 more source
Current role of cytoreductive nephrectomy in metastatic renal cell carcinoma
Urology Research and Practice, 2021 Historically, immediate cytoreductive nephrectomy (CN) was considered the standard of care in patients with metastatic renal cell carcinoma (mRCC) who were fit enough to undergo surgery. Recently, 2 randomized controlled trials, SURTIME and CARMENA, have
Charles Van Praet +9 more
doaj +1 more source
Epidemiological and Histopathological Study of Renal Cell Carcinoma: A Retrospective Study [PDF]
Journal of Clinical and Diagnostic Research, 2022 Introduction: The incidence of Renal Cell Carcinomas (RCCs) has increased steadily and they have become the seventh most common histological type of cancer across the globe.
Amit Kumar +3 more
doaj +1 more source
Cytoreductive nephrectomy in metastatic renal cell carcinoma. [PDF]
Cochrane Database Syst RevNephrectomy is the surgical removal of all or part of a kidney. When the aim of nephrectomy is to reduce tumor burden in people with established metastatic disease, the procedure is called cytoreductive nephrectomy (CN). CN is typically combined with systemic anticancer therapy (SACT).
Dahm P +6 more
europepmc +4 more sources